Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,032 | -5,464 | -9,150 | -6,636 | -4,254 |
| Depreciation Amortization | 124 | 48 | 120 | 80 | 52 |
| Other Working Capital | 2,377 | 1,581 | -720 | -611 | -451 |
| Other Operating Activity | 774 | 428 | 280 | 199 | 128 |
| Operating Cash Flow | $-7,757 | $-3,407 | $-9,470 | $-6,968 | $-4,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -526 | -57 | -300 | -73 | -55 |
| Investing Cash Flow | $-526 | $-57 | $-300 | $-73 | $-55 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -212 | -36 | -23 |
| Common Stock Issued | 393 | 253 | 66 | 66 | 63 |
| Other Financing Activity | 62,606 | 63,259 | 11,966 | 4,722 | 4,722 |
| Financing Cash Flow | $62,999 | $63,512 | $11,820 | $4,752 | $4,762 |
| Beginning Cash Position | 14,192 | 14,192 | 12,150 | 12,152 | 12,152 |
| End Cash Position | 68,908 | 74,240 | 14,190 | 9,863 | 12,334 |
| Net Cash Flow | $54,716 | $60,048 | $2,040 | $-2,289 | $182 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,757 | -3,407 | -9,470 | -6,968 | -4,525 |
| Capital Expenditure | -526 | -57 | -304 | -73 | -55 |
| Free Cash Flow | -8,283 | -3,464 | -9,774 | -7,041 | -4,580 |